Alexandria Real Estate Equities remains a Buy despite market challenges and dividend cuts.

Alexandria Real Estate Equities (ARE) continues to be rated as a Buy due to its strong margin of safety despite facing supply-demand imbalances in key life science markets. The company has taken defensive measures including asset sales, a 45% dividend cut, reduced general and administrative expenses, and shifting towards joint venture capital. Although credit downgrades reflect ongoing challenges, these are largely priced into the stock. The valuation assumes no growth in funds from operations after 2027, yet the fair value estimate of $64.59 per share significantly exceeds current market prices, suggesting potential upside for investors.